Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.

Literature DB >> 20413348

Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism.

Mary V Relling, Russ B Altman, Matthew P Goetz, William E Evans.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20413348 PMCID： PMC4633045 DOI： 10.1016/S1470-2045(10)70097-8

Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316

× No keyword cloud information.

13 in total

1. "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests.

Authors: Michael J Green; Jeffrey R Botkin
Journal: Ann Intern Med Date: 2003-04-01 Impact factor: 25.391

Review 2. Inheritance and drug response.

Authors: Richard Weinshilboum
Journal: N Engl J Med Date: 2003-02-06 Impact factor: 91.245

Review 3. Moving towards individualized medicine with pharmacogenomics.

Authors: William E Evans; Mary V Relling
Journal: Nature Date: 2004-05-27 Impact factor: 49.962

4. Medical genetics: a marker for Stevens-Johnson syndrome.

Authors: Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal: Nature Date: 2004-04-01 Impact factor: 49.962

5. The incidentalome: a threat to genomic medicine.

Authors: Isaac S Kohane; Daniel R Masys; Russ B Altman
Journal: JAMA Date: 2006-07-12 Impact factor: 56.272

Review 6. Pharmacogenetics of opioids.

Authors: Andrew A Somogyi; Daniel T Barratt; Janet K Coller
Journal: Clin Pharmacol Ther Date: 2007-03 Impact factor: 6.875

7. Medicine. Reestablishing the researcher-patient compact.

Authors: Isaac S Kohane; Kenneth D Mandl; Patrick L Taylor; Ingrid A Holm; Daniel J Nigrin; Louis M Kunkel
Journal: Science Date: 2007-05-11 Impact factor: 47.728

Review 8. Pharmacogenetics and cancer therapy.

Authors: M V Relling; T Dervieux
Journal: Nat Rev Cancer Date: 2001-11 Impact factor: 60.716

9. How will GINA influence participation in pharmacogenomics research and clinical testing?

Authors: L G Dressler; S F Terry
Journal: Clin Pharmacol Ther Date: 2009-11 Impact factor: 6.875

10. The sequence of the human genome.

Authors: J C Venter; M D Adams; E W Myers; P W Li; R J Mural; G G Sutton; H O Smith; M Yandell; C A Evans; R A Holt; J D Gocayne; P Amanatides; R M Ballew; D H Huson; J R Wortman; Q Zhang; C D Kodira; X H Zheng; L Chen; M Skupski; G Subramanian; P D Thomas; J Zhang; G L Gabor Miklos; C Nelson; S Broder; A G Clark; J Nadeau; V A McKusick; N Zinder; A J Levine; R J Roberts; M Simon; C Slayman; M Hunkapiller; R Bolanos; A Delcher; I Dew; D Fasulo; M Flanigan; L Florea; A Halpern; S Hannenhalli; S Kravitz; S Levy; C Mobarry; K Reinert; K Remington; J Abu-Threideh; E Beasley; K Biddick; V Bonazzi; R Brandon; M Cargill; I Chandramouliswaran; R Charlab; K Chaturvedi; Z Deng; V Di Francesco; P Dunn; K Eilbeck; C Evangelista; A E Gabrielian; W Gan; W Ge; F Gong; Z Gu; P Guan; T J Heiman; M E Higgins; R R Ji; Z Ke; K A Ketchum; Z Lai; Y Lei; Z Li; J Li; Y Liang; X Lin; F Lu; G V Merkulov; N Milshina; H M Moore; A K Naik; V A Narayan; B Neelam; D Nusskern; D B Rusch; S Salzberg; W Shao; B Shue; J Sun; Z Wang; A Wang; X Wang; J Wang; M Wei; R Wides; C Xiao; C Yan; A Yao; J Ye; M Zhan; W Zhang; H Zhang; Q Zhao; L Zheng; F Zhong; W Zhong; S Zhu; S Zhao; D Gilbert; S Baumhueter; G Spier; C Carter; A Cravchik; T Woodage; F Ali; H An; A Awe; D Baldwin; H Baden; M Barnstead; I Barrow; K Beeson; D Busam; A Carver; A Center; M L Cheng; L Curry; S Danaher; L Davenport; R Desilets; S Dietz; K Dodson; L Doup; S Ferriera; N Garg; A Gluecksmann; B Hart; J Haynes; C Haynes; C Heiner; S Hladun; D Hostin; J Houck; T Howland; C Ibegwam; J Johnson; F Kalush; L Kline; S Koduru; A Love; F Mann; D May; S McCawley; T McIntosh; I McMullen; M Moy; L Moy; B Murphy; K Nelson; C Pfannkoch; E Pratts; V Puri; H Qureshi; M Reardon; R Rodriguez; Y H Rogers; D Romblad; B Ruhfel; R Scott; C Sitter; M Smallwood; E Stewart; R Strong; E Suh; R Thomas; N N Tint; S Tse; C Vech; G Wang; J Wetter; S Williams; M Williams; S Windsor; E Winn-Deen; K Wolfe; J Zaveri; K Zaveri; J F Abril; R Guigó; M J Campbell; K V Sjolander; B Karlak; A Kejariwal; H Mi; B Lazareva; T Hatton; A Narechania; K Diemer; A Muruganujan; N Guo; S Sato; V Bafna; S Istrail; R Lippert; R Schwartz; B Walenz; S Yooseph; D Allen; A Basu; J Baxendale; L Blick; M Caminha; J Carnes-Stine; P Caulk; Y H Chiang; M Coyne; C Dahlke; A Deslattes Mays; M Dombroski; M Donnelly; D Ely; S Esparham; C Fosler; H Gire; S Glanowski; K Glasser; A Glodek; M Gorokhov; K Graham; B Gropman; M Harris; J Heil; S Henderson; J Hoover; D Jennings; C Jordan; J Jordan; J Kasha; L Kagan; C Kraft; A Levitsky; M Lewis; X Liu; J Lopez; D Ma; W Majoros; J McDaniel; S Murphy; M Newman; T Nguyen; N Nguyen; M Nodell; S Pan; J Peck; M Peterson; W Rowe; R Sanders; J Scott; M Simpson; T Smith; A Sprague; T Stockwell; R Turner; E Venter; M Wang; M Wen; D Wu; M Wu; A Xia; A Zandieh; X Zhu
Journal: Science Date: 2001-02-16 Impact factor: 47.728

39 in total

1. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network.

Authors: M V Relling; T E Klein
Journal: Clin Pharmacol Ther Date: 2011-01-26 Impact factor: 6.875

2. Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors: M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal: Clin Pharmacol Ther Date: 2011-01-26 Impact factor: 6.875

3. Genetic advances in medicine: has the promise been fulfilled in general practice?

Authors: Fiona M Walter; Jon D Emery
Journal: Br J Gen Pract Date: 2012-03 Impact factor: 5.386

Review 4. Pharmacogenomics in pediatric leukemia.

Authors: Steven W Paugh; Gabriele Stocco; William E Evans
Journal: Curr Opin Pediatr Date: 2010-12 Impact factor: 2.856

5. NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity.

Authors: Takaya Moriyama; Rina Nishii; Virginia Perez-Andreu; Wenjian Yang; Federico Antillon Klussmann; Xujie Zhao; Ting-Nien Lin; Keito Hoshitsuki; Jacob Nersting; Kentaro Kihira; Ute Hofmann; Yoshihiro Komada; Motohiro Kato; Robert McCorkle; Lie Li; Katsuyoshi Koh; Cesar Rolando Najera; Shirley Kow-Yin Kham; Tomoya Isobe; Zhiwei Chen; Edwynn Kean-Hui Chiew; Deepa Bhojwani; Cynthia Jeffries; Yan Lu; Matthias Schwab; Hiroto Inaba; Ching-Hon Pui; Mary V Relling; Atsushi Manabe; Hiroki Hori; Kjeld Schmiegelow; Allen E J Yeoh; William E Evans; Jun J Yang
Journal: Nat Genet Date: 2016-02-15 Impact factor: 38.330